Thomas Wickham

Thomas Wickham

Company: GentiBio

Job title: CSO


Expert Panel: What Does a Good Treg Cell Product Look Like? 3:30 pm

Taking learnings from other cell therapy products to fuel Treg cell therapy development Discussing the real challenges of developing a Treg cell product to overcome them Understanding the role of IL-2 in Treg cell therapy developmentRead more

day: Day One | Track A | Afternoon

Generating EngTregs to Overcome Key Challenges Associated with the Successful Application of Treg Therapeutics 1:30 pm

Engineering abundant T cell populations with stabilized FOXP3 expression to create a scalable and stable Treg phenotype Utilizing an inducible chimeric receptor to provide highly specific and tunable IL-2 signaling support Providing tissue specificity and enhanced regulatory functions through antigen-specific CARs or TCRsRead more

day: Day One | Track A | Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.